1
Bhagat Hitesh R, Donovan Joanne M, Braunlin William, Sacchiero Robert: Enteric coated aliphatic amine polymer bile acid sequestrants. Genzyme Corporation, Bhagat Hitesh R, Donovan Joanne M, Braunlin William, Sacchiero Robert, DAVIS Steven G, July 21, 2005: WO/2005/065291 (32 worldwide citation)

Tablets, capsules, sachets, or papers having one or more aliphatic amine polymers allow for the targeted release of the polymers at a specific region of the gastrointestinal tract, especially the small intestine. These tablets, capsules, sachets, or papers are useful in a method for lowering cholest ...


2
BURKE STEVEN K, DONOVAN JOANNE M: [fr] Procédés de traitement de syndrome X avec polyamines apliphatiques, [de] Verfahren zur X-Syndrom-Behandlung mit apliphatischen Polyaminen, [en] Methods of treating syndrome X with apliphatic polyamines. GENZYME, April 7, 2010: EP2172204-A1

[en] Disclosed is the use of colesevelam or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the purpose of treating Syndrome X in an individual in need thereof, under the proviso that the medicament does not contain a PTPase inhibitor. Also disclosed is the use of ...


3

4
Burke Steven K, Donovan Joanne M: Utilisation du colesevelam pour reduire le glucose serique, Use of colesevelam in reducing serum glucose. Genzyme Corporation, Genzyme Corporation, Borden Ladner Gervais, June 7, 2011: CA2444046

A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the ...


5
Burke Steven K, Donovan Joanne M: Methods of treating syndrome x with aliphatic polyamines. Genzyme, January 14, 2004: EP1379259-A1

The invention relates to a method for treating Syndrome X, or inhibiting the onset of symptoms of Syndrome X in a patient, and includes administering a therapeutically effective amount of a salt of at least one alkylated and cross-linked polymer, or a copolymer thereof, the polymer salt formed as a ...


6
Bhagat Hitesh R, Donovan Joanne M, Braunlin William, Sacchiero Robert: Enteric coated aliphatic amine polymer bile acid sequestrants. Genzyme, September 13, 2006: EP1699442-A2

Tablets, capsules, sachets, or papers having one or more aliphatic amine polymers allow for the targeted release of the polymers at a specific region of the gastrointestinal tract, especially the small intestine. These tablets, capsules, sachets, or papers are useful in a method for lowering cholest ...


7
Burke Steven K, Donovan Joanne M: Methods of treating syndrome x with aliphatic polyamines. Genzyme Corporation, DAVIS Steven G, October 31, 2002: WO/2002/085382

The invention relates to a method for treating Syndrome X, or inhibiting the onset of symptoms of Syndrome X in a patient, and includes administering a therapeutically effective amount of a salt of at least one alkylated and cross-linked polymer, or a copolymer thereof, the polymer salt formed as a ...


8
Burke Steven K, Donovan Joanne M: Methods of treating syndrome x with aliphatic polyamines. Genzyme Corporation, March 3, 2004: KR1020037013679

The invention relates to a method for treating Syndrome X, or inhibiting the onset of symptoms of Syndrome X in a patient, and includes administering a therapeutically effective amount of a salt of at least one alkylated and cross-linked polymer, or a copolymer thereof, the polymer salt formed as a ...


9